MilliporeSigma
All Photos(2)

GF24083692

Bismuth

foil, not light tested, 100x100mm, thickness 0.015mm, permanent polyester support, 99.97%

Synonym(s):
Bismuth, BI000140
Empirical Formula (Hill Notation):
Bi
CAS Number:
Molecular Weight:
208.98
MDL number:
PubChem Substance ID:
NACRES:
NA.23

vapor pressure

<0.1 mmHg ( 20 °C)

assay

99.97%

form

foil

manufacturer/tradename

Goodfellow 240-836-92

resistivity

129 μΩ-cm, 20°C

size L × W × thickness

100 mm × 100 mm × 0.015 mm

bp

1560 °C (lit.)

mp

271 °C (lit.)

density

9.8 g/mL at 25 °C (lit.)

SMILES string

[Bi]

InChI

1S/Bi

InChI key

JCXGWMGPZLAOME-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

For updated SDS information please visit www.goodfellow.com.

Legal Information

Product of Goodfellow

Certificate of Analysis

Enter Lot Number to search for Certificate of Analysis (COA).

Certificate of Origin

Enter Lot Number to search for Certificate of Origin (COO).

Jorge A R Salvador et al.
Future medicinal chemistry, 4(11), 1495-1523 (2012-08-04)
In recent years, the chemical potential of bismuth and bismuth compounds has been actively exploited. Bismuth salts are known for their low toxicity, making them potential valuable reagents for large-scale synthesis, which becomes more obvious when dealing with products such
Jorge A R Salvador et al.
Molecules (Basel, Switzerland), 16(4), 2884-2913 (2011-04-06)
Steroid and terpene chemistry still have a great impact on medicinal chemistry. Therefore, the development of new reactions or "greener" processes in this field is a contemporaneous issue. In this review, the use of bismuth(III) salts, as "ecofriendly" reagents/catalysts, on
Syntheses of biodegradable and biocompatible polymers by means of bismuth catalysts.
Hans R Kricheldorf
Chemical reviews, 109(11), 5579-5594 (2009-09-26)
Hong Lu et al.
European journal of gastroenterology & hepatology, 25(10), 1134-1140 (2013-06-20)
Antimicrobial resistance has continued to undermine many popular anti-Helicobacter pylori therapies. Antibiotic resistance to commonly used anti-H. pylori drugs in China has increased markedly, making China an ideal site to identify regimens that remain effective despite widespread antimicrobial resistance. Bismuth
P Moayyedi et al.
Alimentary pharmacology & therapeutics, 17(10), 1215-1227 (2003-05-21)
Evidence for the effectiveness of antacids, histamine-2 receptor antagonists, bismuth salts, sucralfate and prokinetic therapy in non-ulcer dyspepsia is conflicting. To conduct a systematic review evaluating these therapies in non-ulcer dyspepsia. Electronic searches were performed using the Cochrane Controlled Trials

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service